These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 35759451)
1. METTL3-mediated m6A modification promotes processing and maturation of Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits. Niu J; Wang B; Wang T; Zhou T Am J Med Genet B Neuropsychiatr Genet; 2022 Apr; 189(3-4):86-99. PubMed ID: 35591810 [TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP. Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729 [TBL] [Abstract][Full Text] [Related]
4. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression. Li S; Lu X; Zheng D; Chen W; Li Y; Li F J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010 [TBL] [Abstract][Full Text] [Related]
5. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth. Wu S; Wang H; Yang Q; Liu Z; Du J; Wang L; Chen S; Lu Q; Yang DH Cancer Lett; 2024 Aug; 597():217058. PubMed ID: 38880226 [TBL] [Abstract][Full Text] [Related]
6. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox. Zhou Y; Li W Environ Toxicol; 2024 Mar; 39(3):1631-1640. PubMed ID: 38018881 [TBL] [Abstract][Full Text] [Related]
7. N6-Methyladenosine reader HNRNPC-mediated downregulation of circITCH prevents miR-224-3p sequestering and contributes to tumorigenesis in nasopharyngeal carcinoma. Zhou Q; Song W; Li X; Lin J; Zhu C; Cao L; Li W; Lin S Environ Toxicol; 2024 May; 39(5):2893-2907. PubMed ID: 38299319 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer. Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602 [TBL] [Abstract][Full Text] [Related]
10. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis. Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of METTL14-mediated m Gong S; Wang S; Shao M J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154 [TBL] [Abstract][Full Text] [Related]
12. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A. Huang Y; Guan Y; Zhang X Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409 [TBL] [Abstract][Full Text] [Related]
13. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940 [TBL] [Abstract][Full Text] [Related]
14. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner. Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135 [TBL] [Abstract][Full Text] [Related]
15. The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA. Yu X; Zhao H; Cao Z Minerva Med; 2022 Apr; 113(2):309-314. PubMed ID: 32512975 [TBL] [Abstract][Full Text] [Related]
16. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells. Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092 [TBL] [Abstract][Full Text] [Related]
17. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells. Cui Z; Zhao Y BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643 [TBL] [Abstract][Full Text] [Related]
18. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion. Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395 [TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1. Bao J; Xu T; Wang W; Xu H; Chen X; Xia R Mol Cell Biochem; 2024 Nov; 479(11):3077-3089. PubMed ID: 38180718 [TBL] [Abstract][Full Text] [Related]
20. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN. Song L; Chen L; Luan Q; Kong Q J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]